We’re experiencing issues for some mobile devices with our ARTG dataset filter function. We apologise for any inconvenience while we work to fix this.
Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
Topic
- Advertising (292)
- COVID-19 (164)
- Safety monitoring and information (120)
- Compliance and enforcement (93)
- Legislation (78)
- Manufacturing (60)
- Vaping hub (57)
- Labelling and packaging (43)
- Import and export (38)
- Medicinal cannabis hub (28)
- Scheduling (national classification system) (27)
- Sunscreens (20)
- Weight loss products (18)
- Shortages and supply disruptions (11)
- Committees and advisory bodies (9)
- Cosmetics (6)
- Unique Device Identification (UDI) hub (5)
- Clinical trials (3)
- Fees and payments (2)
- Prescription opioids hub (2)
- Urogynaecological (transvaginal) surgical mesh hub (2)
- Breast implant hub (1)
Search
1294 result(s) found, displaying 651 to 675
-
Media releasesThe TGA has received an application from GlaxoSmithKline (GSK) Australia Pty Ltd for a higher (1000 mg) dose of its COVID‑19 treatment, sotrovimab (XEVUDY)
-
Regulatory decision noticesListed medicine ingredients and requirements are updated in the Therapeutic Goods (Permissible Ingredients) Determination (No. 3) 2022.
-
Media releasesTransition to the mandatory statement requirements of the 2021 Advertising Code
-
Media releasesShen Neng Herbal Medicines Group Pty Ltd fined $53,280 for alleged breaches of therapeutic goods legislation.
-
COVID-19 vaccine safety reportsInformation about the TGA's safety monitoring of COVID-19 vaccines.
-
-
COVID-19 vaccine safety reportsInformation about the TGA's safety monitoring of COVID-19 vaccines.
-
Media releasesThe TGA has issued an infringement notice for $13,320 to Vaxine Pty Ltd of Adelaide for advertising an unapproved COVID-19 vaccine in alleged breach of the Therapeutic Goods Act 1989.
-
COVID-19 vaccine safety reportsInformation about the TGA's safety monitoring of COVID-19 vaccines.
-
Regulatory decision noticesPrevention notice under section 42DKB of the Therapeutic Goods Act 1989.
-
COVID-19 vaccine safety reportsInformation about the TGA's safety monitoring of COVID-19 vaccines.
-
Media releasesTGA, part of the Department of Health, has granted a second provisional determination to Biocelect Pty Ltd (on behalf of Novavax Inc.) in relation to its COVID-19 vaccine, Nuvaxovid.
-
Media releasesThe TGA has issued an infringement notice of $13,320 to Getafix Café Pty Ltd (the company) for an alleged breach of the Therapeutic Goods Act 1989 in relation to the advertising of a COVID-19 rapid antigen test on its website.
-
Media releasesGold Coast company FuturePro Pty Ltd, trading as Inet Herbal, has pleaded guilty to seven breaches of the Therapeutic Goods Act 1989.
-
Media releasesThe TGA has issued two infringement notices totalling $26,640 to DPD Stores Pty Ltd, trading as Lanyon Newsagency in the ACT, in relation to alleged unlawful supply of nicotine vaping products.
-
Media releasesThe TGA has issued an infringement notice for $7,992 to a Melbourne based Pharmacist for the alleged unlawful advertising of nicotine vaping products.
-
Media releasesThe TGA is urging consumers to only purchase COVID-19 rapid antigen tests (RATs) that are approved for use in Australia to avoid the risk of poor test performance that could arise from using unapproved, repackaged or repurposed RATs.
-
COVID-19 vaccine safety reportsInformation about the TGA's safety monitoring of COVID-19 vaccines.
-
Media releasesThe TGA has issued two infringement notices totalling $26,640 to a Sydney-based company for alleged unlawful advertising of a TENS device.
-
Media releasesConsumers are advised to be cautious about ivermectin products that are sold by unverified online stores.
-
MEPH Pharmacy Pty Ltd fined $39,960 for the alleged unlawful advertising of nicotine vaping products
Media releasesMEPH Pharmacy Pty Ltd fined $39,960 for the alleged unlawful advertising of nicotine vaping products -
Media releasesThe TGA has issued an infringement notice for $2,664 to an individual for a NSW based herbal medicine practitioner for an alleged breach of the Advertising Code.
-
Regulatory decision noticesA new Therapeutic Goods Determination for listed medicine ingredients commences on 1 March 2022.
-
Safety updatesMedicines Safety Update - Information for health professionals
-
Regulatory decision noticesThis labelling exemption is granted under section 1.5.5 of Part 2 of the current Poisons Standard.